Sir, Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization associated with a dome-shaped macula in pathologic myopia

J. H. Lee, Sungchul Lee, S. Choi, H. J. Koh, S. S. Kim, C. S. Lee

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)507-508
Number of pages2
JournalEye (Basingstoke)
Volume31
Issue number3
DOIs
Publication statusPublished - 2017 Mar 1

Fingerprint

Macula Lutea
Degenerative Myopia
Choroidal Neovascularization
Intravitreal Injections
Angiogenesis Inhibitors
Myopia
Visual Acuity
Retrospective Studies
Bevacizumab
Dome

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Sensory Systems

Cite this

@article{33ec531b675e455da1d973d216f2ad9e,
title = "Sir, Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization associated with a dome-shaped macula in pathologic myopia",
author = "Lee, {J. H.} and Sungchul Lee and S. Choi and Koh, {H. J.} and Kim, {S. S.} and Lee, {C. S.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1038/eye.2016.249",
language = "English",
volume = "31",
pages = "507--508",
journal = "Eye",
issn = "0950-222X",
publisher = "Nature Publishing Group",
number = "3",

}

Sir, Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization associated with a dome-shaped macula in pathologic myopia. / Lee, J. H.; Lee, Sungchul; Choi, S.; Koh, H. J.; Kim, S. S.; Lee, C. S.

In: Eye (Basingstoke), Vol. 31, No. 3, 01.03.2017, p. 507-508.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Sir, Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization associated with a dome-shaped macula in pathologic myopia

AU - Lee, J. H.

AU - Lee, Sungchul

AU - Choi, S.

AU - Koh, H. J.

AU - Kim, S. S.

AU - Lee, C. S.

PY - 2017/3/1

Y1 - 2017/3/1

UR - http://www.scopus.com/inward/record.url?scp=85014826474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014826474&partnerID=8YFLogxK

U2 - 10.1038/eye.2016.249

DO - 10.1038/eye.2016.249

M3 - Letter

VL - 31

SP - 507

EP - 508

JO - Eye

JF - Eye

SN - 0950-222X

IS - 3

ER -